The Affordable Medicines Facility-malaria (AMFm): are remote areas benefiting from the intervention?

BACKGROUND: To assess the availability, price and market share of quality-assured artemisinin-based combination therapy (QAACT) in remote areas (RAs) compared with non-remote areas (nRAs) in Kenya and Ghana at end-line of the Affordable Medicines Facility-malaria (AMFm) intervention. METHODS: Areas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Yazoume, Arnold, Fred, Noor, Abdisalan, Wamukoya, Marilyn, Amuasi, John, Blay, Samuel, Mberu, Blessing, Ren, Ruilin, Kyobutungi, Catherine, Wekesah, Frederick, Gatakaa, Hellen, Toda, Mitsuru, Njogu, Julius, Evance, Illah, O’Connell, Kathryn, Shewchuk, Tanya, Thougher, Sarah, Mann, Andrea, Willey, Barbara, Goodman, Catherine, Hanson, Kara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600285/
https://www.ncbi.nlm.nih.gov/pubmed/26452625
http://dx.doi.org/10.1186/s12936-015-0904-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600285/
https://www.ncbi.nlm.nih.gov/pubmed/26452625
http://dx.doi.org/10.1186/s12936-015-0904-z

Ejemplares similares